EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company” or “NovaBay”), today announced the pricing of its underwritten public offering of 3,200,380 shares of common stock (or pre-funded warrants in lieu th…
Category: News
Common Eye Disorder May Be Linked to Maternal Hypertension
Children whose mothers have a hypertensive disorder in pregnancy are at increased risk for strabismus, new research shows. Medscape Medical News
How Age Affects Teprotumumab Tx in Thyroid Eye Disease
Older patients with thyroid eye disease who receive teprotumumab are more likely to require re-treatment. Medscape Medical News
More Anti-VEGF Injections Might Increase Visual Acuity
Greater vision improvements were seen in people with macular edema secondary to retinal vein occlusion who received more anti-VEGF injections over the course of 5 years. Medscape Medical News
National Vision Holdings, Inc. Announces Second Quarter 2024 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its second quarter 2024 financial results before the market opens on Wednesday, August 7, 2024 and will host a conference call a…
National Vision Announces Optometry Students Selected to Win $7,000 in Scholarships
DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear, announced the winners of its 2024 National Optometric Student Association (NOSA) scholarships. Throug…
CenterWell Announces Plans to Open 23 Senior Primary Care Centers at Walmart Locations in Florida, Georgia, Missouri and Texas
LOUISVILLE, Ky.–(BUSINESS WIRE)–CenterWell, the health care services business of Humana Inc. (NYSE: HUM), today announced plans to lease clinical space and open senior-focused primary care centers at 23 Walmart Supercenter retail stores in Florida, G…
Are GLP-1s Bad for Retinas?
A pivotal clinical trial found an increased risk for worsening diabetic retinopathy with semaglutide, but a large database analysis of real-world patients raised questions about that finding. Medscape Medical News
Novel Gene Therapy Safe for Retinitis Pigmentosa
Phase 1/2 clinical trials demonstrated that the gene modifier improves retinal structure, function, and restores homeostasis. Medscape Medical News
GenSight Biologics Reports Cash Position as of June 30, 2024, and Provides Business Update
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
GenSight Biologics publie sa position de trésorerie au 30 juin 2024, et fait le point sur ses activités
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN: FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurodé…
A Cash Giveaway to Improve Health
We can’t just give cash to low-income folks instead of food to improve their health, can we? That’s just what these researchers did. Medscape
Laboratory-Developed Meat: Ethicist Says It’s Worth Pursuing
Ethicist Art Caplan discusses considerations for laboratory-developed meat. Medscape Business of Medicine
Here’s How to Have ‘Greener’ Intravitreal Injections
Simple adjustments can significantly reduce environmental impact without compromising patient care. Medscape Medical News
Spryte Medical Receives Breakthrough Device Designation from FDA for Revolutionary neuro Optical Coherence Tomography (nOCT) Technology
BEDFORD, Mass.–(BUSINESS WIRE)–Spryte Medical, a pioneering company in advanced medical imaging technologies, proudly announces that its neuro Optical Coherence Tomography (nOCT) technology has been granted Breakthrough Device Designation by the U.S….
Ora Announces Strategic Investment from The Vistria Group to Propel Global Growth, Enhance Customer Experience in Ophthalmic Research
BOSTON & CHICAGO–(BUSINESS WIRE)– #Innovation–Leading Ophthalmic CRO Ora announces recapitalization by The Vistria Group, New CEO Paul Colvin
Retinal Detachment Still Sticky Issue for Stickler Syndrome
Gene testing does inform diagnosis, but it can’t tell doctors when to intervene with prophylactic retinal treatments. Medscape Medical News
Filgotinib Cuts Treatment Failures in Uveitis
Filgotinib reduced the risk for treatment failure in patients with active noninfectious uveitis, data from a phase 2 trial showed. Medscape Medical News
Eyes With IOLs Do Worse With In-Office Retina Repair
A study of pneumatic retinopexy for rhegmatogenous retinal detachment showed a 54% success rate in eyes that had cataract surgery and overall success rates far below results of a key clinical trial. Medscape Medical News
New Data for Genentech’s Susvimo Demonstrates Sustained Efficacy in Two Serious Diabetic Eye Conditions
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today two-year data from the Phase III Pagoda and Pavilion studies evaluating Susvimo® (ranibizumab injection) 100 mg/mL for th…